Loop Industries (NASDAQ:LOOP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.19) by 89.47 percent. This is a 90.48 percent increase over losses of $(0.21) per share from the same period last year.
Needham Maintains Buy on Taysha Gene Therapies, Lowers Price Target to $32
Needham analyst Gil Blum maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and lowers the price target from $47 to $32.
